Dermatitis Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends|LEO Pharma AS, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A.

The dermatitis market size is expected to see strong growth in the next few years. It will grow to <b>$8.37 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. </b> The growth in the forecast period can be attributed to growing patient awareness, environmental factors. Major trends in the forecast period include research and development, telemedicine and digital health, biologics and targeted therapies, personalized medicine.

To access more details regarding this report, visit the link:

Segmentation & Regional Insights
The dermatitis market covered in this report is segmented –

1) By Drug Class: Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors
2) By Distribution Channel: Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies
3) By Application: Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases

By Route Of Application: Topical, Oral, Injectable

<b>North America</b> was the largest region in the dermatitis market in 2023. <b>Middle East</b> is expected to be the fastest-growing region in the dermatitis market report during the forecast period. The regions covered in the dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

Major Driver Impacting Market Growth
Growth in the dermatitis market is primarily driven by the increasing global prevalence of the disease. The prevalence of dermatitis in children is estimated to be around 15-20% while it is 1-3% in adults. The rising cases of food allergies are adding to the prevalence of dermatitis which ultimately leads to the increase in demand for medicines to cure this disease. For instance, in October 2022, according to the Global Atopic Dermatitis Atlas (GADA), a report published by the International Eczema Council (IEC), a US-based international dermatology association, approximately 223 million individuals were reported to be affected by atopic dermatitis in 2022. Out of this total, around 43 million were in the age group of 1 to 4 years.

Key Industry Players
Major companies operating in the dermatitis market include <b>LEO Pharma AS, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A., Bayer AG, Encore Dermatology Inc., Meda Pharmaceuticals Inc., Allergan Plc, Bristol-Myers Squibb Co., Anacor Pharmaceutical Inc., Astellas Pharma Inc., Mylan N.V., Valeant Pharmaceutical Inc., Galderma SA, Dow Inc., Connetics Corporation, Fujisawa Pharmaceutical Company Ltd., AbbVie Inc., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International Inc,, GlaxoSmithKline plc, Medimmune Inc., Bausch Health Co. Inc., Nestlé Skin Health India Pvt. Ltd., Aqua Pharmaceuticals Pvt. Ltd., C.H. Boehringer Sohn AG & Co. KG, Biofrontera AG, Zydus Lifesciences Limited</b>

The dermatitis market report table of contents includes:

  1. Executive Summary
  2.   Dermatitis Market          Characteristics
  3.   Dermatitis Market          Trends And Strategies
  4.   Dermatitis Market          – Macro Economic Scenario
  5. Global   Dermatitis Market          Size and Growth




  1. Global   Dermatitis Market          Competitive Benchmarking
  2. Global   Dermatitis Market          Competitive Dashboard
  3. Key Mergers And Acquisitions In   Dermatitis Market
  4.   Dermatitis Market          Future Outlook and Potential Analysis
  5. Appendix


Top Major Players :

  • LEO Pharma AS
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc
  • Sanofi S.A.


Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
Healthcare Blog:
Global Market Model:

Leave a Reply

Your email address will not be published. Required fields are marked *